• MJHLS Brand Logo

© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.

CBI Biosimilars Summit

Is It Time for a Global Reference Product for Biosimilars?

January 26th 2019

Article

On the last day of the 14th Biosimilars Summit, held January 22-23, 2019, in Alexandria, Virginia, the head of the FDA practice at Avalere discussed her point of view that enabling a global reference product for biosimilars would provide global access for patients.

Managing Risk Can Ensure Biosimilar Rewards, Expert Says

January 24th 2019

Article

Despite the challenges inherent in biosimilars, they have a fairly high probability of success, said Edric Engert, managing director of Abraxeolus Consulting, in a presentation at the 14th Biosimilars Summit, held January 22-23, 2019, in Alexandria, Virginia.

Businesses Have a Financial Stake in Promoting Biosimilars, Employer Groups Say

January 24th 2019

Article

At a panel discussion at the 14th Biosimilars Summit, held January 22-23, 2019, in Alexandria, Virginia, representatives of employer groups discussed the role that businesses have in driving the discussion about raising awareness and adoption of biosimilars. Employer groups can help overcome barriers, such as patient fears and misinformation, and create confidence about using biosimilars, speakers said.

Creating and Sustaining Best Practices in Launching Biosimilars

January 24th 2019

Article

Before launching into a discussion of what firms need to consider when identifying “best practices” to get a biosimilar up and running in a new market, Mylan’s global commercial head for biologics and insulin gave a quick history lesson about how far the field has come in a keynote address at the 14th Biosimilars Summit, held January 22-23, 2019, in Alexandria, Virginia.

What's New in Medicare Part B for Biosimilars

January 23rd 2019

Article

The current administration in Washington, DC, is one of the most active when it comes to policy and regulation that affects biosimilars, said a presenter who recapped recent changes for the attendees at the 14th Biosimilars Summit, held January 22-23, 2019, in Alexandria, Virginia.